Our study showed that downregulation of FYB1 effectively inhibited the growth of T-ALL cells both in vitro and in vivo by inhibiting cell proliferation and promoting apoptosis (Figures 3 and 4). The gene discussed is FYB1; the disease is acute lymphoblastic leukemia.